Thus, for early diagnosis it will also be necessary to validate GAS5 as well as the previously identified RP1-86D1.3 [7] in a prospective study regarding their potential to detect mesothelioma in prediagnostic plasma samples and to complement calretinin and mesothelin. This evidence concerns the gene MSLN and mesothelioma.